为了研究施普瑞在防治恶性肿瘤化疗后白细胞降低的作用 ,我科于 1994年 11月至 1998年 5月间对化疗病人予以施普瑞口服 ,取得一定疗效 ,现将结果报告如下 :临床资料 :病例选择 :本组病人共 90例 ,经病理证实为恶性肿瘤 ,包括肺癌、胃癌、乳腺癌、恶性淋巴瘤、脑胶质瘤、鼻咽癌 In order to study the role of Spr in preventing leukopenia after chemotherapy for malignant tumors, our department administered spruy orally to chemotherapy patients from November 1994 to May 1998. The results are reported as follows: Clinical data : Case selection: A total of 90 patients in this group were confirmed by pathology as malignant tumors, including lung cancer, gastric cancer, breast cancer, malignant lymphoma, glioma, nasopharyngeal carcinoma